Assessing the Financial Toxicity Associated With Treatment Options for Resectable Pancreatic Cancer

被引：0
|
作者：
Cerullo, Marcelo
Gani, Faiz
Canner, Joseph K.
Pawlik, Timothy M.
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)34057-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1024
引用
收藏
页码：S1200 / S1200
页数：1
相关论文
共 50 条
  • [21] RESULTS OF SURGICAL TREATMENT OF RESECTABLE PANCREATIC CANCER
    Potrc, Stojan
    Hazabent, Marko
    Ivanecz, Arpad
    Horvat, Matjaz
    Jagric, Tomaz
    ANNALS OF ONCOLOGY, 2011, 22 : v57 - v57
  • [22] Current Concepts in the Treatment of Resectable Pancreatic Cancer
    Marc T. Roth
    Jordan D. Berlin
    Current Oncology Reports, 2018, 20
  • [23] MULTIDISCIPLINARY TREATMENT FOR RESECTABLE PANCREATIC-CANCER
    OZAKI, H
    HOJO, K
    KATO, H
    KINOSHITA, T
    EGAWA, S
    KISHI, K
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1988, 3 (04) : 249 - 260
  • [24] Current Concepts in the Treatment of Resectable Pancreatic Cancer
    Roth, Marc T.
    Berlin, Jordan D.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (05)
  • [25] Financial Toxicity of Cancer Treatment
    Hussaini, M. Qasim
    Gupta, Arjun
    Dusetzina, Stacie B.
    JAMA ONCOLOGY, 2022, 8 (05) : 788 - 788
  • [26] Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer
    Heinemann, V.
    Haas, M.
    Boeck, S.
    ANNALS OF ONCOLOGY, 2013, 24 (10) : 2484 - 2492
  • [27] Multimodality standard of care treatment of resectable and borderline resectable pancreatic cancer
    Neoptolemos, John P.
    Ghaneh, Paula
    Hackert, Thilo
    HEPATOBILIARY SURGERY AND NUTRITION, 2021, 10 (05) : 714 - 716
  • [28] Perioperative treatment options in resectable pancreatic cancer- how to improve long-term survival
    Marianne Sinn
    Marcus Bahra
    Timm Denecke
    Sue Travis
    Uwe Pelzer
    Hanno Riess
    World Journal of Gastrointestinal Oncology, 2016, 8 (03) : 248 - 257
  • [29] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [30] Pancreatic cancer - Are there new treatment options?
    Tepel, Juergen
    Kalthoff, Holger
    LIVER AND PANCREATIC DISEASES MANAGEMENT, 2006, 574 : 107 - 110
12345